About SFM Clinical Research, LLC
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
3
Theravance Biopharma
2
ACADIA Pharmaceuticals Inc.
1
Cartesian Therapeutics
1
Eli Lilly and Company
1
Otsuka Pharmaceutical Development & Commercialization, Inc.
1
Regeneron Pharmaceuticals
1
Samus Therapeutics, Inc.
1
Takeda
1
Clinical Trials at SFM Clinical Research, LLC
During the past decade, SFM Clinical Research, LLC conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 2 clinical trials were completed, i.e. on
average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
The INSYTE (Management of Parkinson's Disease Psychosis in Actual Practice) Study
2017-03-30
2021-03-08
Terminated
764
Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
2017-10-13
2024-03-01
Recruiting
550
Clinical Effect of Ampreloxetine (TD-9855) for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure
2019-01-24
2021-07-21
Completed
195
Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure
2019-02-22
2021-11-10
Terminated
203
A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
2019-08-12
2028-04-04
Recruiting
1,000
Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG)
2019-12-04
2023-12-01
Recruiting
30
A Study of TAK-079 in People With Generalized Myasthenia Gravis
2020-01-20
2022-07-12
Completed
36
To Evaluate Safety, Tolerability and Pharmacological Effects of PU AD in Subjects With Mild AD Dementia
2020-06-30
2022-11-15
Terminated
4
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "SFM Clinical Research, LLC" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Theravance Biopharma" with 2 trials
sponsored, "ACADIA Pharmaceuticals Inc." with 1 trials sponsored, "Cartesian Therapeutics" with 1 trials sponsored and "Eli Lilly and Company"
with 1 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 9 trials in total.
Clinical Trials Conditions at SFM Clinical Research, LLC
According to Clinical.Site data, the most researched conditions in "SFM Clinical Research, LLC" are
"Alzheimer Disease" (2 trials), "Symptomatic Neurogenic Orthostatic Hypotension" (2 trials), "Agitation in Patients With Dementia of the Alzheimer's Type" (1 trials), "Generalized Myasthenia Gravis" (1 trials) and "MSA" (1 trials). Many other conditions were trialed in "SFM Clinical Research, LLC" in a lesser frequency.
Clinical Trials Intervention Types at SFM Clinical Research, LLC
Most popular intervention types in "SFM Clinical Research, LLC" are "Drug" (11 trials), "Other" (2 trials), "Behavioral" (1 trials), "Diagnostic Test" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "Ocrelizumab" (2 trials), "ampreloxetine" (2 trials), "AVP-786" (1 trials) and "Antihistamine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at SFM Clinical Research, LLC
The vast majority of trials in "SFM Clinical Research, LLC" are
12 trials for "All" genders.
Clinical Trials Status at SFM Clinical Research, LLC
Currently, there are NaN active trials in "SFM Clinical Research, LLC".
undefined are not yet recruiting,
7 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in SFM Clinical Research, LLC,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in SFM Clinical Research, LLC, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".